Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Opinion on Biological Therapy|May 10, 2024
Switching CGRP(r) MoAbs in migraine: what evidence?William David Wells-Gatnik, Paolo Martelletti
International Journal of Environmental Research and Public Health|November 26, 2022
Reaching the Nadir of Medication Overuse in Chronic MigraineDilara Onan, William David Wells-Gatnik, Paolo Martelletti
Expert Review of Neurotherapeutics|September 12, 2024
Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraineWilliam David Wells-Gatnik, Lanfranco Pellesi, Paolo Martelletti
Drugs & Aging|February 24, 2023
New Migraine Drugs for Older AdultsDilara Onan, William David Wells-Gatnik, Enrico Bentivegna, et al.
Expert Opinion on Investigational Drugs|September 6, 2023
Emerging experimental drugs in clinical trials for migraine: observations and key talking pointsWilliam David Wells-Gatnik, Tiffany Yazmin Wences Chirino, Fatma Nur Onan, et al.
The Journal of Headache and Pain|October 2, 2025
Application of machine learning in migraine classification: a call for study design standardization and global collaborationIgor Petrušić, Roberta Messina, Lanfranco Pellesi, et al.
Cephalalgia : an International Journal of Headache|June 5, 2026
Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE studyFederico De Santis, Chiara Rosignoli, Agnese Onofri, et al.
The Journal of Headache and Pain|August 15, 2025
Longitudinal assessment of migraine burden in resistant and refractory migraine - Data from the prospective REFINE studyUmberto Pensato, Raffaele Ornello, Chiara Rosignoli, et al.
Pageof 1